247 related articles for article (PubMed ID: 19761101)
1. [Drug therapy of type 2 diabetes and cardiovascular prevention: potentials for liraglutide].
Reboldi G
G Ital Cardiol (Rome); 2009 Jul; 10(7):434-47. PubMed ID: 19761101
[TBL] [Abstract][Full Text] [Related]
2. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
Montanya E; Sesti G
Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide: a new treatment for type 2 diabetes.
Vilsboll T
Drugs Today (Barc); 2009 Feb; 45(2):101-13. PubMed ID: 19343230
[TBL] [Abstract][Full Text] [Related]
4. Next-generation GLP-1 therapy: an introduction to liraglutide.
Repas T
Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes.
Davies MJ; Kela R; Khunti K
Diabetes Obes Metab; 2011 Mar; 13(3):207-20. PubMed ID: 21205109
[TBL] [Abstract][Full Text] [Related]
6. An overview of the pharmacokinetics, efficacy and safety of liraglutide.
Bode B
Diabetes Res Clin Pract; 2012 Jul; 97(1):27-42. PubMed ID: 22245694
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide (Victoza) for type 2 diabetes.
Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
[TBL] [Abstract][Full Text] [Related]
8. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
Gross B
J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.
Ryan GJ; Hardy Y
J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide in type 2 diabetes: from pharmacological development to clinical practice.
Rossi MC; Nicolucci A
Acta Biomed; 2009 Aug; 80(2):93-101. PubMed ID: 19848045
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
Bode B
Am J Manag Care; 2011 Mar; 17(2 Suppl):S59-70. PubMed ID: 21517658
[TBL] [Abstract][Full Text] [Related]
12. The future use of liraglutide: implications of the LEAD-2 study for treatment guidelines in type 2 diabetes.
Gadsby R
Prim Care Diabetes; 2010 Oct; 4(3):139-44. PubMed ID: 20418194
[TBL] [Abstract][Full Text] [Related]
13. Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents.
Blonde L; Montanya E
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():20-32. PubMed ID: 22405266
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide for type 2 diabetes?
Drug Ther Bull; 2010 May; 48(5):50-3. PubMed ID: 20447980
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide.
Watson E; Jonker DM; Jacobsen LV; Ingwersen SH
J Clin Pharmacol; 2010 Aug; 50(8):886-94. PubMed ID: 20133507
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide: clinical pharmacology and considerations for therapy.
Sisson EM
Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction.
Morrow L; Hompesch M; Guthrie H; Chang D; Chatterjee DJ
Diabetes Obes Metab; 2011 Jan; 13(1):75-80. PubMed ID: 21114606
[TBL] [Abstract][Full Text] [Related]
18. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
Jahn E; Sausele T
Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
[TBL] [Abstract][Full Text] [Related]
19. Beyond glycemic control: treating the entire type 2 diabetes disorder.
Brunton S
Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
[TBL] [Abstract][Full Text] [Related]
20. Is treatment with liraglutide efficient?
Mezquita Raya P; Reyes García R
Endocrinol Nutr; 2014 Apr; 61(4):202-8. PubMed ID: 24071060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
